Joanna M. Melia

Joanna M. Melia

Gastroenterology

2360 West Joppa Road, Joppa Concourse STE 205
Joppa Concourse STE 205
Lutherville, MD 21093

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

An Integrated Large-Scale Atlas of Protein Quantitative Trait Loci across Olink and SomaScan platforms.

An Integrated Large-Scale Atlas of Protein Quantitative Trait Loci across Olink and SomaScan platforms.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cells.

Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cells.

Journal: Inflammatory bowel diseases

Published: November 17, 2025

Mycobacterium tuberculosis subverts macrophage-mediated defense through exploitation of the Zn transporter ZIP8.

Mycobacterium tuberculosis subverts macrophage-mediated defense through exploitation of the Zn transporter ZIP8.

Journal: iScience

Published: August 12, 2025

Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study.

Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study.

Journal: Inflammatory bowel diseases

Published: June 30, 2025

Longitudinal TCR repertoires in ulcerative colitis patients show features distinguishing disease states.

Longitudinal TCR repertoires in ulcerative colitis patients show features distinguishing disease states.

Journal: Inflammatory bowel diseases

Published: May 30, 2025

Aberrant N-glycosylation may be a therapeutic target in carriers of a common and highly pleiotropic variant in the manganese transporter ZIP8.

Aberrant N-glycosylation may be a therapeutic target in carriers of a common and highly pleiotropic variant in the manganese transporter ZIP8.

Journal: HGG advances

Published: March 27, 2025

Outcomes Associated With Anti-Depressant Use in Patients With Inflammatory Bowel Disease.

Outcomes Associated With Anti-Depressant Use in Patients With Inflammatory Bowel Disease.

Journal: Alimentary pharmacology & therapeutics

Published: February 11, 2025

Longitudinal T cell repertoire analysis reveals dynamic clonal T cell populations in Ulcerative Colitis.

Longitudinal T cell repertoire analysis reveals dynamic clonal T cell populations in Ulcerative Colitis.

Journal: bioRxiv : the preprint server for biology

Published: January 27, 2025

Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease.

Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease.

Journal: American journal of preventive cardiology

Published: December 09, 2024

Editorial: Striving for Equitable Care in Ulcerative Colitis-Authors' Reply.

Editorial: Striving for Equitable Care in Ulcerative Colitis-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: December 03, 2024

Care of Patients With Inflammatory Bowel Disease With Inadequate Response or Intolerance to Upadacitinib.

Care of Patients With Inflammatory Bowel Disease With Inadequate Response or Intolerance to Upadacitinib.

Journal: Gastro hep advances

Published: November 18, 2024

Aberrant N-glycosylation is a therapeutic target in carriers of a common and highly pleiotropic mutation in the manganese transporter ZIP8.

Aberrant N-glycosylation is a therapeutic target in carriers of a common and highly pleiotropic mutation in the manganese transporter ZIP8.

Journal: bioRxiv : the preprint server for biology

Published: July 15, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026